$VRSK

Verisk (VRSK) Down 4.7% Since Last Earnings Report: Can It Rebound?

Verisk (VRSK) shares fell 4.7% since its last earnings report. Q2 2026 earnings beat estimates at $1.98 per share, up 5.3% YoY. Revenue rose 4.3% to $806.3M. Underwriting and claims revenues increased 3.5% and 6.3% respectively. EBITDA grew 4.2% but net income declined 9.8% due to higher taxes and interest. The company maintained 2026 guidance and approved a dividend. Estimates have trended downward, with a Zacks Rank #3 (Hold).

Original reporting
Published Aug 28, 2026, 3:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 29, 2026, 6:38 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Verisk (VRSK) Down 4.7% Since Last Earnings Report: Can It Rebound? — source image
Decision brief

The 30-second read

$VRSKBullishMed
01

Why it matters

Earnings beat and reaffirmed guidance provide a modest bullish catalyst for the stock

02

Market read

Verisk's results may modestly improve its stock and the broader insurance analytics sector

03

What to watch

Higher tax rate and legal expenses may erode margins

Relevance 8/10Novelty 8/10Timing: after market close

Background

Article reviews Verisk's Q2 2026 earnings, revenue growth, cash flow boost, share repurchase program and reaffirmed outlook

Company-level read

Ticker impact

$VRSKBullishMedium confidence
Context

Q2 2026 diluted adjusted earnings of $1.98 per share beat estimates and guidance reaffirmed

Expected impact

Potential modest price rise or stabilization after recent decline

Evidence & confidence

Beat and $200M share repurchase suggest buying interest, but unchanged outlook and weaker estimates limit upside

Market effects

Boosts sentiment for insurance data and analytics sector

May lift US insurance stocks

Limited to US market

Counterpoint

Momentum score decline and downward estimate revisions could pressure the stock despite earnings beat

Key entities

  • Verisk Analytics

    Insurance data and analytics provider

Related articles

$VRSKMed

VRSK Maintained by Barclays -- Price Target Lowered to $225

Barclays maintained an Overweight rating on Verisk Analytics (VRSK) but lowered its price target from $275 to $225. The company's stock is trading at $179.17, which GuruFocus estimates is 44.4% undervalued. Verisk has a GF Score of 78/100, indicating strong profitability and growth, but lower momentum. Insider activity shows significant selling, with $2.55 million in sales over the past three months.

$VRSKMed

Is Verisk’s Q2 Beat, Buyback and AI Push Altering The Investment Case For Verisk Analytics (VRSK)?

Verisk Analytics (VRSK) reported Q2 2026 earnings and revenue above estimates, reaffirmed its 2026 outlook, and announced a $200M share repurchase. The company emphasized growth in AI and data analytics for insurance clients. Verisk projects $3.8B in revenue and $1.3B in earnings by 2029, with a 24% upside to its current price. The company's high debt levels and interest expenses remain key risks.

$VRSKMedAI 8/10

Verisk Analytics v. AccuLynx: Sorry, You Actually DO Have To Comply With That Second Request

The Delaware Court of Chancery ordered Verisk Analytics to continue pursuing FTC clearance for its $2.35 billion acquisition of AccuLynx, despite Verisk's attempt to terminate the deal. The court ruled that Verisk's termination was invalid due to its willful conduct in ending negotiations with a competitor, ServiceTitan. Verisk must now comply with a costly Second Request process, which typically takes many months to complete. The court's decision is notable as it is the first to compel a buyer